Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Curaleaf Holdings Inc T.CURA

Alternate Symbol(s):  CURLF

Curaleaf Holdings, Inc. is an international provider of consumer cannabis products. The Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof provide selection and accessibility across the medical and adult use markets. It operates in approximately 17 states and owns and operates 147 dispensaries and 21 cultivation sites with a focus on states, including Arizona, Florida, Illinois, Massachusetts, New Jersey, New York and Pennsylvania. It cultivates, processes, markets and/or dispenses a range of permitted cannabis products across its operating markets, including flower and pre-rolls, dry-herb vaporizer cartridges, concentrates for vaporizing such as pre-filled vaporizer cartridges and disposable vaporizer pens, concentrates for dabbing, such as mints, topical balms and lotions, tinctures, lozenges, capsules and edibles. Through Curaleaf International Holdings Limited, it has a supply and distribution network throughout the European market.


TSX:CURA - Post by User

Comment by blackspade799on Dec 06, 2021 3:42pm
87 Views
Post# 34203513

RE:Cura

RE:CuraFood For Thought; MSO's trade at 8x 2023 EBITDA while offering 25% profit growth. S&P trades at 12.8x for 8% growth. Giving MSO's the same multiple/growth ratio suggests MSO's *should* trade at 40x. Easy to see the 5x rerating opportunity. CURA also got EMMAC for nothing Gave EMMAC $50Mil and 17.5Mil in Shares. Received $130Mil Private investor in the deal gave up 30 Points. So CURA International sitting on over $80Mil cash, Germany about to legalize, EAMMAC deal would now be closer to $1 Billion. Dont forget CURA is being taxed 80% we need 280E and SAFE will be a major game changer. CURA also have 6-7 new Medical stores to add before yr end. This is just the tip of the iceburg, Im not even going to get into Select NJ,NY,FL. Worring about the day to day swing is poinless. Adding and Holding CURA is the smart play, CURA is the largest Cannabis company in the world and growing every mth. 36 out of 50 states with some kid of cannabis,CURA has 113 Medical Stors and 2100+ Wholesale and growing. New finacial deal on the way. Short sighted investors can not see the forrest for the trees. CURA is a great buy all day!
<< Previous
Bullboard Posts
Next >>